Sunday, December 3, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Assistant Professor
Department of Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia
Associate Professor
Department of Hematology and Medical Oncology
Medical Director
Winship Data and Technology Applications Shared Resource
Winship Cancer Institute of Emory University
Atlanta, Georgia
Director
Judy and Bernard Briskin Center for Multiple Myeloma Research
Professor
Department of Hematology and Hematopoietic Cell Transplantation
City of Hope Medical Center
Duarte, California
Associate Professor
Center Medical Director
Department of Lymphoma/Myeloma
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, Georgia
Associate Professor of Medicine
Division of Hematology/Oncology
Medical College of Wisconsin
Milwaukee, Wisconsin
Adjunct Faculty
Nell Hodgson Woodruff School of Nursing
Advanced Practice Provider Chief
Winship Cancer Institute of Emory University
Atlanta, Georgia
Clinical Pharmacy Specialist
Emory Healthcare
Atlanta, Georgia
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for hematologists/oncologists, nurses, nurse practitioners (NPs), physician assistants (PAs), and pharmacists involved in the care of patients with hematologic disorders, including leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), benign hematologic diseases, and other related conditions.
The goal of this activity is that learners will be better able to personalize treatment for patients with multiple myeloma in an interprofessional team-based environment by integrating clinical trial data and evidence-based recommendations on novel therapies.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Professor of Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
Rochester, Minnesota
Assistant Professor
Department of Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Atlanta, Georgia
Associate Professor
Department of Hematology and Medical Oncology
Medical Director
Winship Data and Technology Applications Shared Resource
Winship Cancer Institute of Emory University
Atlanta, Georgia
Director
Judy and Bernard Briskin Center for Multiple Myeloma Research
Professor
Department of Hematology and Hematopoietic Cell Transplantation
City of Hope Medical Center
Duarte, California
Associate Professor
Center Medical Director
Department of Lymphoma/Myeloma
Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas
Chair and Professor
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, Georgia
Associate Professor of Medicine
Division of Hematology/Oncology
Medical College of Wisconsin
Milwaukee, Wisconsin
Adjunct Faculty
Nell Hodgson Woodruff School of Nursing
Advanced Practice Provider Chief
Winship Cancer Institute of Emory University
Atlanta, Georgia
Clinical Pharmacy Specialist
Emory Healthcare
Atlanta, Georgia
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 2.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 2.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 2.25 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 2.50 contact hour(s) (0.250 CEUs) (Universal Activity Number: JA0007105-0000-22-360-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 10/11/2022
Valid for credit through: 10/11/2023, 11:59 PM EST
processing....
All sections of this activity are required for credit.
The goal of this activity is that learners will be better able to personalize treatment for patients with multiple myeloma
in an interprofessional team-based environment by integrating clinical trial data and evidence-based recommendations on novel
therapies.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions
again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
